Hatime Arzu Yasar (H Arzu Yasar, H Arzu Yaşar, Hatime A Yaşar, H Arzu Yaşar, Arzu Yaşar, Hatime Arzu Yaşar)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Ulcerative Colitis

Prognostic Factors

Palliative Care

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

European journal of cancer care

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Beliz Bahar Karaoğlan, Emre Yekedüz, Satı Coşkun Yazgan, Eda Eylemer Mocan, Elif Berna Koksoy, Hatime Arzu Yasar, Filiz Çay Şenler, Gungor Utkan, Ahmet Demirkazık, Hakan Akbulut, Yuksel Urun
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors. Immunotherapy (2024)
Hatime Arzu Yasar, Olgu Erkin Çinar, Nur Yazdali Köylü, Ibrahim Barista, Hakan Goker, Yahya Buyukasik
Central nervous system involvement in patients with acute myeloid leukemia Turkish journal of medical sciences 51 (5) (2021)
Emre Yekedüz, Hatime Arzu Yasar, Güngör Utkan, Yuksel Urun
A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2020)
Hatime Arzu Yasar, Erman Akkus, Aylin Heper, Bengu N Akay, Yuksel Urun, Gungor Utkan
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (7) (2020)
Mutlu Hizal, Mehmet An Sendur, Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, Gokhan Ucar, Serdar Karakaya, Hakan Taban, Ahmet Kucukarda, Ismail Erturk, Burak Bilgin, Nuriye Yıldırım, Umut Demirci, Saadettin Kılıckap, Irfan Cicin, Nuri Karadurmus, Bulent Yalcin, Yuksel Urun
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study). Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (7) (2020)
Ali Alkan, Hatime Arzu Yasar, Zeynep Gülsüm Sevgen Güç, Mustafa Gürbüz, Tuğba Başoğlu, Sema Sezgin Göksu, Fatma Bugdayci Basal, Hacı Mehmet Türk, Özlem Özdemir, Havva Yeşil Çinkir, Deniz Can Guven, Tülay Kuş, Sema Türker, Lokman Koral, Yusuf Karakas, Naziye Ak, Semra Paydaş, Ebru Karcı, Atike Gökçen Demiray, Atakan Demir, Özkan Alan, Özge Keskin, Erdinç Nayır, Ozgur Tanrıverdi, Tugba Yavuzsen, Perran Fulden Yumuk, Ozturk Ates, Hasan Şenol Coşkun, Nazım Serdar Turhal, Filiz Çay Şenler
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). European journal of cancer care 29 (6) (2020)
Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, Gokhan Ucar, Serdar Karakaya, Burak Bilgin, Hakan Taban, Ahmet Kucukarda, Ismail Erturk, Mutlu Hızal, Birol Yıldız, Nuriye Yıldırım, Umut Demirci, Mehmet Ali Sendur, Gungor Utkan, Saadettin Kılıckap, Irfan Cicin, Nuri Karadurmus, Yuksel Urun
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)
Yuksel Urun, Hatime Arzu Yasar, Hande Turna, Saadettin Kılıçkap, Ahmet Sezer, Berna Öksüzoğlu, Nuriye Özdemir, Ma Nahit Şendur, Hüseyin Abalı
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (8) (2019)
Hatime Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan, Berna Oksuzoglu, Nuriye Ozdemir, Ma Nahit Sendur, Ahmet Sezer, Saadettin Kılıckap, Gungor Utkan, Hakan Akbulut, Ismail Celik, Huseyin Abalı, Yuksel Urun
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (2) (2019)
Ali Alkan, Hatime Arzu Yasar, Serhat Toprak
Kaposi sarcoma associated with rituximab-based cytotoxic therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (1) (2019)
Yuksel Urun, Hatime Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan, Berna Oksuzoglu, Nuriye Ozdemir, Ma Nahit Sendur, Ahmet Sezer, Saadettin Kılıckap, Gungor Utkan, Tulay Akman, Hakan Akbulut, Ismail Celik, Huseyin Abalı
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (7) (2018)